Attenuation of inflammation by emodin in lipopolysaccharide-induced acute kidney injury via inhibition of toll-like receptor 2 signal pathway

Iranian Journal of Kidney Diseases

Volumn 9, Issue 3, 2015, Pages 202-208

  Li, Ying ^a   Xiong, Weijian ^a   Yang, Jing ^a   Zhong, Jin ^a   Zhang, Ling ^a   Zheng, Jing ^a   Liu, Hong ^a   Zhang, Qi ^a   Ouyang, Xiaoqin ^a   Lei, Lei ^a   Yu, Xiao ^a  

^a Chongqing Hospital of Traditional Chinese Medicine   (China)

Author keywords

Acute kidney injury; Emodin; Inflammation; Lipopolysaccharides; Toll like receptor 2

Indexed keywords

EMODIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY ASSAY; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ACUTE KIDNEY INJURY; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; METABOLISM;

ACUTE KIDNEY INJURY; ANIMALS; CELLS, CULTURED; EMODIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928992500     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kellum JA. Acute kidney injury. Crit Care Med. 2008;36:S141-S145.
2. Theilig F, Kriz W, Jerichow T, et al. Abrogation of protein uptake through megalin-deficient proximal tubules does not safeguard against tubulointerstitial injury. J Am Soc Nephrol. 2007;18:1824-34.
3. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007;35:1837-43.
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
5. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol. 2007;19:48-55.
6. Zager RA, Johnson AC, Lund S, Randolph-Habecker J. Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol. 2007;292:F304-F312.
7. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol. 2001;2:346-52.
8. Scherberich JE, Hartinger A. Impact of Toll-like receptor signalling on urinary tract infection. Int J Antimicrob Agents. 2008;31 Suppl 1:S9-14.
9. Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol. 2006;145:346-56.
10. China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China (First Division of 2000 ed). Beijing: China Chemical Industry Press; p. 181999.
11. Li S, Dong X, Wu H, Zhang L, Zhang D. Progress in studies on pharmacological effect of rhubarb and its active components. Med Recapitulate. 2005;1:76-8.
12. Kwak HJ, Park MJ, Park CM, et al. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer. 2006;118:2711-20.
13. Jia X, Iwanowycz S, Wang J, et al. Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Exp Biol Med (Maywood). 2014;239:1025-35.
14. Yang Z, Zhou E, Wei D, et al. Emodin inhibits LPSinduced inflammatory response by activating PPARgamma in mouse mammary epithelial cells. Int Immunopharmacol. 2014;21:354-60.
15. Lei T, Zhou XC, Cai SQ. The clinical observation of different administration route and douses of rhubarb in acute pancreatitis. Guide China Med. 2011;28:1671-8194.
16. Chen RF, Shen YC, Huang HS, et al. Evaluation of the anti-inflammatory and cytotoxic effects of anthraquinones and anthracenes derivatives in human leucocytes. J Pharm Pharmacol. 2004;56:915-9.
17. Kitano A, Saika S, Yamanaka O, et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci. 2007;48:5013-22.
18. Li Z, Xia X, Zhang S, Zhang A, Bo W, Zhou R. Up regulation of Toll-like receptor 4 was suppressed by emodin and baicalin in the setting of acute pancreatitis. Biomed Pharmacother. 2009;63:120-8.
19. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3:169-76.
20. El-Achkar TM, Dagher PC. Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol. 2006;2:568-81.
21. Leemans JC, Stokman G, Claessen N, et al. Renalassociated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005;115:2894-903.
22. Leemans JC, Butter LM, Pulskens WP, et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One. 2009;4:e5704.
23. Wang J, Huang H, Liu P, et al. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats. Eur J Pharmacol. 2006;553:297-303.
24. Yeboah MM, Xue X, Duan B, et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int. 2008;74:62-9.
25. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70:358-62.